Affiliation:
1. College of Veterinary Science and Animal Husbandry, Anjora - 491001, Durg, C.G., India.
2. Columbia Institute of Pharmacy, Raipur, 493111, Chhattisgarh.
Abstract
The viral pandemic in India has presented a complex and challenging scenario since 2019, impacting the nation's public health, economy, and social fabric. This abstract provides a concise overview of the key aspects concerning the new virus H9N2. H9N2 is primarily an avian influenza virus, and while it has occasionally infected humans, those cases have generally been limited and the virus has not shown sustained human-to-human transmission. This paper explores the structural components of H9N2, determinant of host tropism, antigenic characteristics, transmission pattern, and symptoms after viral entry, complications, preventive measures, therapeutic measures, research and surveillance and role of Government for prevention and eradication of viral pandemic and measures need to be taken by the government to mitigate economic fallout etc. Special attention is given to the identification of hotspots and the effectiveness of containment measures. The abstract concludes with an exploration of the challenges faced many countries during the viral pandemic during the recent past and the lessons learned in terms of preparedness, response mechanisms, and the need for global cooperation in addressing future pandemics. Paper also serves as a snapshot of the multifaceted impact of the viral pandemic in India, offering insights into the country's response strategies and the broader implications for public health and society.
Reference32 articles.
1. WANG YanWen, WANG MengJing, ZHANG Hong, GAO Xin Xin, GUO Jing, LI XuYong. Evolution of Human H9N2 Avian Influenza Virus in China from 1998 to 2021[J]. Scientia Agricultura Sinica. 2022; 55(20): 4075-4090.
2. Sorrell EM, Wan H, Araya Y, Song H, Perez DR. Minimal molecular constraints for respiratory droplet transmission of an avian-human H9N2 influenza A virus. Proc Natl Acad Sci USA. 2009; 106: 7565–7570.
3. National Institute of Allergy and Infectious Diseases NIH http://www3.niaid.nih.gov/news/focuson/flu/illustrations/timeline/2007
4. Kand un IN, Wibisono H, Sedyaningsih ER, Yusharmen HW, Purba W, Santoso H, Septiawati C, Tresnaningsih E, Heriyanto B et al. Three Indonesian clusters of H5N1 virus infection in 2005. N Engl J Med. 2006; 355:2186–2194.
5. de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, Chau TN, Hoang DM, Chau NV, Khanh TH, Dong VC et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med. 2006; 12:1203–1207.